Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Efficacy similar with naproxcinod and naproxen in osteoarthritis patients

Nov. 23, 2007

MQX-503 reduces the severity of Raynaud's phenomenon in clinical studies

Nov. 23, 2007

TMC-435350 safe in phase I trial in heathy volunteers

Nov. 23, 2007

Antichlamydial treatment does not improve intermittent claudication symptoms

Nov. 22, 2007

Improvement seen with baminercept in rheumatoid arthritis patients

Nov. 22, 2007

Studies reveal efficacy of golimumab in ankylosing spondylitis, psoriatic arthritis

Nov. 22, 2007

Objective responses seen with SGN-35 in phase I Hodgkin's lymphoma study

Nov. 22, 2007

Nitazoxanide improves responses to standard care in HCV genotype 4 patients

Nov. 22, 2007

Antimalarial noninferiority of Coarsucam and Coartem demonstrated

Nov. 22, 2007

Clinical trials show anti-hepatitis C virus activity of telaprevir therapy

Nov. 22, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...